Exonics Therapeutics
Latest round
- Series A
Last raised
- Nov 2017
Total raised
- $45M
Investors
- 2
About Exonics Therapeutics
Founded in 2017 and based in Massachusetts, US, Exonics Therapeutics, Inc. operates as a biotechnology company that focuses on developing SingleCut CRISPR, a gene repair technology for the treatment of neuromuscular diseases.
Who invested in Exonics Therapeutics
2 investors across 2 rounds
See all investors in Exonics Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Exonics Therapeutics
Who invested in Exonics Therapeutics?
Exonics Therapeutics has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Exonics Therapeutics raised?
Exonics Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Exonics Therapeutics last raise money?
Exonics Therapeutics's most recent round on record is a Series A, in Nov 2017.
What does Exonics Therapeutics do?
Founded in 2017 and based in Massachusetts, US, Exonics Therapeutics, Inc.
Where is Exonics Therapeutics headquartered?
Exonics Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Exonics Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Exonics Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Exonics Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.